UK markets close in 7 hours 28 minutes

ReShape Lifesciences Inc. (RSLS)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.1852-0.0317 (-14.62%)
At close: 04:00PM EDT
0.1899 +0.00 (+2.54%)
After hours: 07:59PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-10,918
-11,387
-46,214
-63,146
-21,630
-
Depreciation & amortisation
112
154
2,153
1,971
1,667
-
Deferred income taxes
30
28
-423
-248
-86
-
Stock-based compensation
616
766
2,087
12,227
1,323
-
Change in working capital
-3,633
-4,134
709
-2,712
6
-
Inventory
-253
-465
-1,187
-369
-1,175
-
Other working capital
-14,007
-17,003
-22,033
-15,727
-8,940
-
Other non-cash items
-283
17
-23
627
1,948
-
Net cash provided by operating activities
-13,971
-16,960
-21,902
-15,375
-8,550
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-43
-131
-352
-390
-
Acquisitions, net
-
-
0
-3,000
-2,000
-2,000
Net cash used for investing activities
-3
-10
-92
1,855
-2,390
-
Cash flows from financing activities
Debt repayment
-
-
0
-10,500
0
-2,200
Common stock issued
-
-
639
0
0
478
Common stock repurchased
-
-
-
-
-
0
Other financing activities
-
13,438
639
-3,234
-59
-
Net cash used provided by (used for) financing activities
7,373
17,574
3,130
33,299
11,075
-
Net change in cash
-6,604
604
-18,860
19,808
22
-
Cash at beginning of period
9,083
3,955
22,815
3,007
2,985
-
Cash at end of period
2,482
4,559
3,955
22,815
3,007
-
Free cash flow
Operating cash flow
-13,971
-16,960
-21,902
-15,375
-8,550
-
Capital expenditure
-
-43
-131
-352
-390
-
Free cash flow
-14,007
-17,003
-22,033
-15,727
-8,940
-